Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taiwan Association of Thoracic and Cardiovascular Surgery (TATCS) Position Statement: Surgeon's Role in the Present Era of Isolated Severe Aortic Stenosis Patient Management.

Acta Cardiologica Sinica·2026
Same author

Reimbursement policy and outcomes after transcatheter aortic valve implantation.

Journal of the Chinese Medical Association : JCMA·2026
Same author

Impact of stent materials and hemodynamic changes after endovascular aneurysm repair for abdominal aortic aneurysm.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Bioinspired Adaptive Leg-Claw Enables Robust Perching and Grasping for UAVs.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Dual-action oral platform for integrated systemic and gut-targeted treatment of acute kidney injury.

Biomaterials·2026
Same author

Oral Magnetoelectric Neuroimmunomodulation via the Gut-Brain-Spleen-Heart Axis for Noninvasive Atrial Fibrillation Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026
Same journal

Recurrence after modified Type III cordectomy for glottic cancer: Predisposing factors and management.

Journal of the Chinese Medical Association : JCMA·2026
Same journal

Incidence of Jarisch-Herxheimer Reaction After Syphilis Treatment and the Role of Awareness Effect.

Journal of the Chinese Medical Association : JCMA·2026
Same journal

Respiratory syncytial virus infection in adults: Clinical manifestations, outcomes, and vaccines.

Journal of the Chinese Medical Association : JCMA·2026
Same journal

Causal effects among hypertension, osteoporosis, and metabolites: A Mendelian randomization study.

Journal of the Chinese Medical Association : JCMA·2026
Same journal

Clinical utility of preoperative lymphocyte-albumin-neutrophil ratio for prognostication in oral cancer patients undergoing surgery.

Journal of the Chinese Medical Association : JCMA·2026
Same journal

Effects of insulin and exenatide therapy on glycemic control and β-cell function in patients newly diagnosed with type 2 diabetes and severe hyperglycemia.

Journal of the Chinese Medical Association : JCMA·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Malignancy after heart transplantation.

Po-Lin Chen1, Hsiao-Huang Chang, I-Ming Chen

  • 1Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.

Journal of the Chinese Medical Association : JCMA
|December 2, 2009
PubMed
Summary
This summary is machine-generated.

Cancer after heart transplantation is a significant concern, with post-transplant lymphoproliferative disease (PTLD) being the most common malignancy. Early detection and treatment are crucial for patient survival and allograft preservation.

More Related Videos

Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

Area of Science:

  • Cardiology
  • Oncology
  • Transplantation Medicine

Background:

  • Malignancies are a known complication following organ transplantation.
  • Understanding the spectrum of cancers post-heart transplant is vital for patient management.

Purpose of the Study:

  • To determine the incidence and types of cancers diagnosed after heart transplantation.
  • To analyze cancer characteristics in a Taiwanese patient cohort.

Main Methods:

  • Retrospective analysis of 66 heart transplant recipients surviving over 30 days.
  • Data collected from January 1987 to December 2008.

Main Results:

  • Eight malignancies (12.1%) were diagnosed in the study cohort.
  • The most frequent malignancy was post-transplant lymphoproliferative disease (PTLD) (n=5).
  • Other cancers included prostate cancer, lung cancer, and squamous cell carcinoma.

Conclusions:

  • Cancer represents a significant challenge to long-term survival after heart transplantation.
  • PTLD is the predominant malignancy in this population.
  • Prompt diagnosis and assertive management improve outcomes and protect the transplanted heart.